MDM2 knockdown mediated by a triazine-modified dendrimer in the treatment of non-small cell lung cancer

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and the five-year survival rate is lower in advanced NSCLC patients. Chemotherapy is a widely used strategy in NSCLC treatment, but is usually limited by poor therapeutic efficacy and adverse effects. Therefore, a new therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Quan, Li, Lei, Li, Lin, Chen, Hui, Dang, Yongyan, Zhang, Jishen, Shao, Naimin, Chang, Hong, Zhou, Zhengjie, Liu, Chongyi, He, Bingwei, Wei, Haifeng, Xiao, Jianru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190075/
https://www.ncbi.nlm.nih.gov/pubmed/27259273
http://dx.doi.org/10.18632/oncotarget.9768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190075/
https://www.ncbi.nlm.nih.gov/pubmed/27259273
http://dx.doi.org/10.18632/oncotarget.9768

Ejemplares similares